Clinical Trials Browser

Phase 1 × Platinum-resistant Recurrent Ovarian Cancer × Clear all

NCT06687070 2025-02-26

APG-2449 Monotherapy or in Combination With PLD in Patients With Platinum-resistant Recurrent OC or Advanced ST

Phase 1 Recruiting

GynecologicOther solid neoplasm

Platinum-resistant Recurrent Ovarian Cancer